Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $12.02, but opened at $9.84. Bavarian Nordic shares last traded at $9.74, with a volume of 23,319 shares.
Bavarian Nordic Price Performance
The company has a market capitalization of $2.28 billion, a price-to-earnings ratio of 11.03 and a beta of 1.23. The firm’s fifty day simple moving average is $12.16 and its 200 day simple moving average is $10.53.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last issued its earnings results on Friday, August 22nd. The company reported $0.23 earnings per share for the quarter. Bavarian Nordic had a return on equity of 12.35% and a net margin of 21.95%.The company had revenue of $251.14 million for the quarter. Equities research analysts forecast that Bavarian Nordic will post 0.67 earnings per share for the current fiscal year.
Bavarian Nordic Company Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
See Also
- Five stocks we like better than Bavarian Nordic
- What Is WallStreetBets and What Stocks Are They Targeting?
- Tempus AI: Volatility Equates to Opportunity in AI Leader
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Follow the Money: 3 Stocks With High Institutional Ownership
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Can Gold Mining Stocks Shine as the Metals Rally Falters?
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
